Bronze Sponsor

Croda International Plc, a specialty chemical company providing high purity and high quailty excipients for drug and vaccine development, has strengthened their offering with the recent acquisition of Brenntag Biosector.  Providing customers with 80 years of adjuvant expertise, Croda Vaccine Adjuvants (formerly Biosector) has unprecedented industry experience as a vaccine adjuvant specialist, with their product portfolio comprising of innovative aluminium- and saponin-based adjuvants.  Croda now offers the industry renowned product portfolio of adjuvants, including the well-known brands Alhydrogel® and Adju-Phos®, as well as a range of technically advanced saponin-based adjuvant systems and a robust pipeline of next generation technology.

Sign Up for Event Updates